SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-114775
Filing Date
2023-11-06
Accepted
2023-11-06 16:30:18
Documents
4
Period of Report
2023-12-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2329176-2_def14a.htm DEF 14A 388850
2 GRAPHIC lg_bellerophon-4clr.jpg GRAPHIC 18422
3 GRAPHIC px_23bellproxy01pg01-4clr.jpg GRAPHIC 221161
4 GRAPHIC px_23bellproxy01pg02-4clr.jpg GRAPHIC 166269
  Complete submission text file 0001104659-23-114775.txt   947272
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 231380357
SIC: 2834 Pharmaceutical Preparations